RAAX vs. ENVB
RAAX (VanEck Inflation Allocation ETF) is Diversified Portfolio fund actively managed by VanEck, while ENVB (Enveric Biosciences Inc) is a stock. Over the past 5 years, RAAX returned 13.26%/yr vs -85.10%/yr for ENVB. At a 0.18 correlation, their price movements are largely independent.
Performance
RAAX vs. ENVB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RAAX achieves a 16.55% return, which is significantly higher than ENVB's -59.23% return.
RAAX
- 1D
- -0.92%
- 1M
- -2.75%
- YTD
- 16.55%
- 6M
- 16.67%
- 1Y
- 30.86%
- 3Y*
- 20.30%
- 5Y*
- 13.26%
- 10Y*
- —
ENVB
- 1D
- -3.27%
- 1M
- -34.22%
- YTD
- -59.23%
- 6M
- -72.39%
- 1Y
- -89.81%
- 3Y*
- -87.52%
- 5Y*
- -85.10%
- 10Y*
- -74.86%
RAAX vs. ENVB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
RAAX VanEck Inflation Allocation ETF | 16.55% | 26.74% | 12.50% | 6.71% | 1.51% | 21.56% | -8.27% | 6.14% | -2.41% |
ENVB Enveric Biosciences Inc | -59.23% | -94.37% | -72.43% | -37.50% | -95.53% | -37.16% | -34.51% | -48.17% | -88.05% |
Correlation
The correlation between RAAX and ENVB is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Apr 10, 2018 | 0.18 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RAAX vs. ENVB — Risk / Return Rank
RAAX
ENVB
RAAX vs. ENVB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Inflation Allocation ETF (RAAX) and Enveric Biosciences Inc (ENVB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RAAX | ENVB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.70 | ||
| Sortino ratioReturn per unit of downside risk | +3.90 | ||
| Omega ratioGain probability vs. loss probability | 1.40 | 0.87 | +0.53 |
| Calmar ratioReturn relative to maximum drawdown | 4.33 | -0.98 | +5.31 |
| Martin ratioReturn relative to average drawdown | 15.50 | -1.34 | +16.85 |
Loading charts...
Drawdowns
RAAX vs. ENVB - Drawdown Comparison
The maximum RAAX drawdown since its inception was -33.91%, smaller than the maximum ENVB drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for RAAX and ENVB.
Loading charts...
Drawdown Indicators
| RAAX | ENVB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -33.91% | -100.00% | +66.09% |
Max Drawdown (1Y)Largest decline over 1 year | -7.17% | -91.49% | +84.32% |
Max Drawdown (3Y)Largest decline over 3 years | -11.59% | -99.81% | +88.22% |
Max Drawdown (5Y)Largest decline over 5 years | -23.55% | -100.00% | +76.45% |
Max Drawdown (10Y)Largest decline over 10 years | — | -100.00% | — |
Current DrawdownCurrent decline from peak | -4.66% | -100.00% | +95.34% |
Average DrawdownAverage peak-to-trough decline | -6.77% | -86.07% | +79.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.00% | 66.73% | -64.73% |
Volatility
RAAX vs. ENVB - Volatility Comparison
The current volatility for VanEck Inflation Allocation ETF (RAAX) is 4.71%, while Enveric Biosciences Inc (ENVB) has a volatility of 21.07%. This indicates that RAAX experiences smaller price fluctuations and is considered to be less risky than ENVB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RAAX | ENVB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.71% | 21.07% | -16.36% |
Volatility (6M)Calculated over the trailing 6-month period | 12.23% | 105.59% | -93.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.21% | 175.01% | -160.80% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.71% | 155.96% | -140.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.79% | 164.65% | -148.86% |
Dividends
RAAX vs. ENVB - Dividend Comparison
RAAX's dividend yield for the trailing twelve months is around 2.01%, while ENVB has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
ENVB Enveric Biosciences Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RAAX VanEck Inflation Allocation ETF | 2.01% | 2.34% | 1.91% | 3.66% | 1.53% | 8.72% | 6.27% | 2.37% | 0.56% |
Frequently Asked Questions
RAAX and ENVB have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ENVB has higher volatility (21.07%) compared to RAAX (4.71%). In terms of maximum drawdown, RAAX dropped -33.91% vs ENVB's -100.00%.
RAAX currently has the higher Sharpe Ratio (2.19 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RAAX and ENVB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer